10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2006 | |
| Sales | 146,313 | 71,085 | 0 |
| Cost of Goods | 28,661 | 10,560 | N/A |
| Gross Profit | 117,652 | 60,525 | N/A |
| Operating Expenses | 229,077 | 79,460 | 0 |
| Operating Income | -110,764 | -18,375 | N/A |
| Interest Expense | 2,409 | 811 | 0 |
| Other Income | 775 | 445 | 0 |
| Pre-tax Income | -112,398 | -18,741 | 0 |
| Income Tax | 87 | 21 | N/A |
| Net Income Continuous | -112,485 | -18,762 | N/A |
| Net Income | $-112,485 | $-18,762 | $N/A |
| EPS Basic Total Ops | -8.40 | -1.62 | N/A |
| EPS Basic Continuous Ops | -8.40 | -1.62 | N/A |
| EPS Diluted Total Ops | -8.40 | -1.62 | N/A |
| EPS Diluted Continuous Ops | -8.40 | -1.62 | N/A |
| EBITDA(a) | $-106,859 | $-14,070 | $N/A |